Smolen JS - Search Results

1

Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis.

Aletaha D, Kapral T, Smolen JS. Aletaha D, et al. Among authors: smolen js. Ann Rheum Dis. 2003 May;62(5):482-6. doi: 10.1136/ard.62.5.482. Ann Rheum Dis. 2003. PMID: 12695166 Free PMC article.

2

Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.

Machold KP, Neumann K, Smolen JS. Machold KP, et al. Among authors: smolen js. Ann Rheum Dis. 1992 Sep;51(9):1039-43. doi: 10.1136/ard.51.9.1039. Ann Rheum Dis. 1992. PMID: 1417133 Free PMC article. Clinical Trial.

3

Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.

Graninger WB, Hassfeld W, Pesau BB, Machold KP, Zielinski CC, Smolen JS. Graninger WB, et al. Among authors: smolen js. J Rheumatol. 1991 Oct;18(10):1621-2. J Rheumatol. 1991. PMID: 1765991

4

Serum osteocalcin concentrations in patients with rheumatoid arthritis.

Pietschmann P, Machold KP, Wolosczuk W, Smolen JS. Pietschmann P, et al. Among authors: smolen js. Ann Rheum Dis. 1989 Aug;48(8):654-7. doi: 10.1136/ard.48.8.654. Ann Rheum Dis. 1989. PMID: 2789500 Free PMC article.

5

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, Smolen JS, Khaltaev N, Muirden KD. Boers M, et al. Among authors: smolen js. J Rheumatol Suppl. 1994 Sep;41:86-9. J Rheumatol Suppl. 1994. PMID: 7799394

6

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity.

Smolen JS, Breedveld FC, Eberl G, Jones I, Leeming M, Wylie GL, Kirkpatrick J. Smolen JS, et al. Arthritis Rheum. 1995 Jan;38(1):38-43. doi: 10.1002/art.1780380106. Arthritis Rheum. 1995. PMID: 7818569

7

Early arthritis therapy: rationale and current approach.

Machold KP, Eberl G, Leeb BF, Nell V, Windisch B, Smolen JS. Machold KP, et al. Among authors: smolen js. J Rheumatol Suppl. 1998 Jul;53:13-9. J Rheumatol Suppl. 1998. PMID: 9666413 Review.

8

T cell derived cytokines in psoriatic arthritis synovial fluids.

Partsch G, Wagner E, Leeb BF, Bröll H, Dunky A, Smolen JS. Partsch G, et al. Among authors: smolen js. Ann Rheum Dis. 1998 Nov;57(11):691-3. doi: 10.1136/ard.57.11.691. Ann Rheum Dis. 1998. PMID: 9924213 Free PMC article.

9

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R. Smolen JS, et al. Lancet. 1999 Jan 23;353(9149):259-66. doi: 10.1016/s0140-6736(98)09403-3. Lancet. 1999. PMID: 9929017 Clinical Trial.

10

Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis.

Köller M, Aringer M, Kiener H, Erlacher L, Machold K, Eberl G, Studnicka-Benke A, Graninger W, Smolen J. Köller M, et al. Ann Rheum Dis. 1999 Nov;58(11):709-12. doi: 10.1136/ard.58.11.709. Ann Rheum Dis. 1999. PMID: 10531076 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

884 results

Search Page

Filters